These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4127122)

  • 1. Electrophysiological phenomena associated with the S-protein system in normal and schizophrenic subjects.
    Cowen MA
    Biol Psychiatry; 1973 Oct; 7(2):113-27. PubMed ID: 4127122
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid transport and the plasma factor in schizophrenia.
    Frohman CE; Warner KA; Barry CT; Arthur RE
    Biol Psychiatry; 1969 Jul; 1(3):201-7. PubMed ID: 4187516
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and mechanism of action of the anti-S protein in human brain.
    Frohman CE; Arthur RE; Yoon HS; Gottlieb JS
    Biol Psychiatry; 1973 Aug; 7(1):53-61. PubMed ID: 4127168
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformation of a unique plasma protein in schizophrenia.
    Frohman CE; Harmison CR; Arthur RE; Gottlieb JS
    Biol Psychiatry; 1971; 3(2):113-21. PubMed ID: 4103784
    [No Abstract]   [Full Text] [Related]  

  • 5. Validity of plasma factor in schizophrenia as measured by tryptophan uptake.
    Guchhait RB; Janson C; Price WH
    Biol Psychiatry; 1975 Jun; 10(3):303-14. PubMed ID: 49200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of schizophrenic patients' plasma on 14C-tryptophan incorporation in chicken erythrocytes].
    Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(6):872-6. PubMed ID: 676614
    [No Abstract]   [Full Text] [Related]  

  • 7. An electrophysiological study on the effects of tryptophan and cortisol on schizophrenic and other mentally ill patient groups and on normal subjects.
    Cowen MA
    Biol Psychiatry; 1976 Aug; 11(4):389-401. PubMed ID: 986840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stimulating effect of schizophrenic patients' plasma on the cellular incorportation of tryptophan in vitro].
    Mukhin AG; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(7):941-7. PubMed ID: 572682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A theory of neuronal malfunction in schizophrenia.
    Gottlieb JS; Frohman CE; Beckett PG
    Am J Psychiatry; 1969 Aug; 126(2):149-56. PubMed ID: 4185016
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia--new concepts.
    Gottlieb JS; Frohman CE; Harmison CR
    South Med J; 1971 Jun; 64(6):743-9. PubMed ID: 4103649
    [No Abstract]   [Full Text] [Related]  

  • 11. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontal lobe cognition disorders in 42 schizophrenic patients compared with 19 normal probands].
    Jaquet I; Lançon C; Auquier P; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):34-41. PubMed ID: 9172966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
    Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absence of frontal lobe dysfunction and working memory deficits in young schizophrenic patients].
    Moreaud O; Peguet I; Naegele B; Vincent T; Chabannes JP; Pellat J
    Encephale; 1998; 24(1):52-6. PubMed ID: 9559304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative EEG in 'positive' and 'negative' schizophrenia.
    Begić D; Hotujac L; Jokić-Begić N
    Acta Psychiatr Scand; 2000 Apr; 101(4):307-11. PubMed ID: 10782551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MRI findings in schizophrenic patient with frontal lobe atrophy].
    Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
    Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of alpha-2-globulins.
    Gordon M
    Arzneimittelforschung; 1970 Aug; 20(8):1152-6. PubMed ID: 4098284
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research into the biochemical bases of schizophrenic syndromes: a review].
    Laplante M; St-Laurent J
    Union Med Can; 1973 Nov; 102(11):2267-78. PubMed ID: 4134633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.